ConductScience.org, home

Paper27261908

Classification and Pathology of Lung Cancer.

Zheng M. Surg Oncol Clin N Am, 2016. Cited by 276 papers, by iCite.

Cite this record

ConductScience Library. Classification and Pathology of Lung Cancer. Papers, record 27261908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27261908

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Classification and Pathology of Lung Cancer.
PubMed
Journal
Surg Oncol Clin N Am
PubMed
Year
2016
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
276
iCite
Relative citation ratio, by iCite
9.62
iCite
Revised in PubMed
2022-04-09
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zheng MMin

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoid TumorMajor topic
Carcinoma, NeuroendocrineMajor topic
Lung NeoplasmsMajor topic
Neuroendocrine TumorsMajor topic
Small Cell Lung CarcinomaMajor topic
Humans

Cited by201

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 276 citations.

PMIDTitleJournalYearIn PapersSource
42582931Epigenetics in lung cancer precision medicine: from bench to bedside-a narrative review.Transl Lung Cancer Res2026https://conductscience.org/library/papers/42582931PubMed
42569776GNN-EGG: Graph neural network explanations via graph generation.Neurocomputing (Amst)2026https://conductscience.org/library/papers/42569776PubMed
42548795Tumor-associated neutrophils in lung adenocarcinoma: from mechanisms to therapeutic targeting.Front Immunol2026https://conductscience.org/library/papers/42548795PubMed
42435178Targeting Lung Cancer Metabolism: Therapeutic Opportunities and Challenges.Adv Exp Med Biol2026https://conductscience.org/library/papers/42435178PubMed
42415103Automated lung cancer classification using intensity-driven RoI selection and transfer learning.BMC Med Inform Decis Mak2026https://conductscience.org/library/papers/42415103PubMed
42292412Tumor-immune crosstalk in lung cancer: emerging roles of long non-coding RNAs.Front Immunol2026https://conductscience.org/library/papers/42292412PubMed
42193278In Vitro Cell Viability and Migration Inhibitory Effects of Isorhamnetin in Non-Small Cell Lung Cancer Cells.Biomedicines2026https://conductscience.org/library/papers/42193278PubMed
42183023Functional role of long non-coding RNA MALAT1 and HOTAIR in lung cancer.Noncoding RNA Res2026https://conductscience.org/library/papers/42183023PubMed
42147259Immunohistochemistry as a Cornerstone in Lung Cancer Diagnosis: Subtyping Based on the 2021 World Health Organization Classification and Its Practical Application.World J Oncol2026https://conductscience.org/library/papers/42147259PubMed
42012657
Co-treatment of Colchicine and Rosiglitazone synergistically inhibits cytokine-driven inflammation and modulates the related hsa-miRNA26a-5p, hsa-miRNA21-5p, and STAT3 expression in non-small cell lung cancer.
Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42012657PubMed
42009743Hybrid supervised deep learning for lung adenocarcinoma diagnosis to optimize surgical strategies.NPJ Precis Oncol2026https://conductscience.org/library/papers/42009743PubMed
41924446Functional significance of miR-218 in lung cancer.J Cancer Metastasis Treat2026https://conductscience.org/library/papers/41924446PubMed
41877597PrPC Glycoprotein Modulates Atmospherically Relevant Artificial Particulate Matter-Induced Development of Lung Cancer in Mice.Environ Sci Technol2026https://conductscience.org/library/papers/41877597PubMed
41854102Altered DNA Methyltransferase Expression in Pulmonary Large-Cell Neuroendocrine Carcinoma: Pilot Experimental Data Targeted DNMT1, DNMT3A, and DNMT3B.Cancer Rep (Hoboken)2026https://conductscience.org/library/papers/41854102PubMed
41825247Three years of chemotherapy tolerance with concurrent Ayurvedic treatment in a metastatic lung adenocarcinoma: A case report.J Ayurveda Integr Med2026https://conductscience.org/library/papers/41825247PubMed
41685607Suppressive role of SCN4B in the epithelial‑mesenchymal transition of lung adenocarcinoma.Oncol Rep2026https://conductscience.org/library/papers/41685607PubMed
41601785P2RY13+ dendritic cells correlate with enhanced antigen presentation and lymphocyte activation in lung adenocarcinoma.Front Med (Lausanne)2025https://conductscience.org/library/papers/41601785PubMed
41465234Molecular and System-Level Characterization of MMP12 Suppression in Lung Cancer: A Combined Bioinformatics and Molecular Approach.Int J Mol Sci2025https://conductscience.org/library/papers/41465234PubMed
41430026Detection of circulating tumor cells and microemboli in the blood of lung adenocarcinoma in situ patients case reports.Discov Oncol2025https://conductscience.org/library/papers/41430026PubMed
41229734A bibliometric analysis of research trends and global perspectives on lung large cell neuroendocrine cancer.J Thorac Dis2025https://conductscience.org/library/papers/41229734PubMed

See all 201 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/27261908

GET https://conductscience.org/api/papers/v1/27261908/cited_by?page=2